Wai Chun Bio-Technology Ltd. (0660) Financial Statements
0 Followers
Wai Chun Bio-Technology Ltd. Financial Overview
Wai Chun Bio-Technology Ltd.'s market cap is currently HK$165.25M. The company's EPS TTM is HK$-0.04; its P/E ratio is -11.11; Wai Chun Bio-Technology Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 24 | Jun 23 | Jun 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 377.17M | HK$ 370.07M | HK$ 773.65M | HK$ 671.46M | HK$ 567.55M |
| Gross Profit | HK$ 36.00M | HK$ 34.18M | HK$ 50.41M | HK$ 60.12M | HK$ 48.93M |
| Operating Income | HK$ 5.36M | HK$ 1.45M | HK$ 11.06M | HK$ 20.81M | HK$ 11.15M |
| EBITDA | HK$ 17.90M | HK$ -48.90M | HK$ 25.12M | HK$ 31.61M | HK$ 17.52M |
| Net Income | HK$ -14.62M | HK$ -44.21M | HK$ -15.43M | HK$ -14.36M | HK$ 995.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 21.45M | HK$ 2.16M | HK$ 6.31M | HK$ 7.52M | HK$ 5.45M |
| Total Assets | HK$ 214.66M | HK$ 209.50M | HK$ 240.23M | HK$ 249.95M | HK$ 188.32M |
| Total Debt | HK$ 95.19M | HK$ 135.90M | HK$ 134.34M | HK$ 151.28M | HK$ 129.78M |
| Net Debt | HK$ 88.63M | HK$ 133.74M | HK$ 128.02M | HK$ 143.76M | HK$ 124.33M |
| Total Liabilities | HK$ 277.31M | HK$ 264.74M | HK$ 229.69M | HK$ 243.91M | HK$ 201.29M |
| Stockholders' Equity | HK$ -91.08M | HK$ -79.25M | HK$ -35.01M | HK$ -37.73M | HK$ -37.49M |
| Cash Flow | |||||
| Free Cash Flow | HK$ -27.03M | HK$ 12.05M | HK$ 17.23M | HK$ -16.40M | HK$ -12.96M |
| Operating Cash Flow | HK$ 1.42M | HK$ 52.09M | HK$ 48.89M | HK$ 390.00K | HK$ -413.00K |
| Investing Cash Flow | HK$ -26.01M | HK$ -40.03M | HK$ -28.18M | HK$ -16.69M | HK$ -12.52M |
| Financing Cash Flow | HK$ 31.34M | HK$ -16.12M | HK$ -23.18M | HK$ 17.07M | HK$ 11.53M |
Currency in HKD
